berberine has been researched along with Pulmonary Arterial Remodeling in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine is a natural product that shows benefits for metabolic syndrome (MS)." | 7.81 | Berberine Attenuates Vascular Remodeling and Inflammation in a Rat Model of Metabolic Syndrome. ( Gao, HQ; Ji, XP; Li, CB; Li, XX; Wang, HW; Xiao, J; Zhang, C; Zhang, XY, 2015) |
| "Berberine is a natural product that shows benefits for metabolic syndrome (MS)." | 3.81 | Berberine Attenuates Vascular Remodeling and Inflammation in a Rat Model of Metabolic Syndrome. ( Gao, HQ; Ji, XP; Li, CB; Li, XX; Wang, HW; Xiao, J; Zhang, C; Zhang, XY, 2015) |
| "Rat models of type 2 diabetes mellitus (T2DM) were established and were treated with berberine." | 1.62 | Macrovascular Protecting Effects of Berberine through Anti-inflammation and Intervention of BKCa in Type 2 Diabetes Mellitus Rats. ( Chen, M; Gu, L; Si, Y; Wu, Z; Yin, W; Zhang, T; Zhao, M, 2021) |
| "Berberine has several preventive effects on cardiovascular diseases." | 1.46 | Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. ( Jian, X; Li, P; Ping, S; Wan, GR; Yin, YL; Yu, HY; Zhu, ML, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, S | 1 |
| Kan, J | 1 |
| Zhang, J | 1 |
| Ye, P | 3 |
| Wang, D | 1 |
| Jiang, X | 2 |
| Li, M | 1 |
| Zhu, L | 3 |
| Gu, Y | 3 |
| Wang, L | 1 |
| Deng, L | 1 |
| Lin, N | 1 |
| Shi, Y | 1 |
| Chen, J | 1 |
| Zhou, Y | 1 |
| Chen, D | 1 |
| Liu, S | 1 |
| Li, C | 1 |
| Wu, Z | 1 |
| Gu, L | 1 |
| Si, Y | 1 |
| Yin, W | 1 |
| Zhao, M | 1 |
| Zhang, T | 1 |
| Chen, M | 2 |
| Zhu, ML | 1 |
| Yin, YL | 1 |
| Ping, S | 1 |
| Yu, HY | 1 |
| Wan, GR | 1 |
| Jian, X | 1 |
| Li, P | 1 |
| Luo, J | 1 |
| Liu, P | 2 |
| Yu, W | 1 |
| Chao, Y | 1 |
| Yang, H | 2 |
| Zhou, L | 1 |
| Chen, S | 2 |
| Shen, H | 1 |
| Li, XX | 1 |
| Li, CB | 1 |
| Xiao, J | 1 |
| Gao, HQ | 1 |
| Wang, HW | 1 |
| Zhang, XY | 1 |
| Zhang, C | 1 |
| Ji, XP | 1 |
7 other studies available for berberine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
Topics: Animals; Antihypertensive Agents; Berberine; Cell Movement; Cell Proliferation; Cells, Cultured; Cop | 2021 |
Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI/ERS and MAPK pathways.
Topics: Animals; Apoptosis; Atherosclerosis; Berberine; Cell Proliferation; Cells, Cultured; China; Endoplas | 2020 |
Macrovascular Protecting Effects of Berberine through Anti-inflammation and Intervention of BKCa in Type 2 Diabetes Mellitus Rats.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Berberine; Cell Movement; Cell Proliferation; Ce | 2021 |
Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inducing Agents; Animals; Berberine; Cell Proliferation; | 2017 |
Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro.
Topics: Animals; Apoptosis; Berberine; Cell Movement; Cell Proliferation; Disease Models, Animal; Gene Expre | 2018 |
Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
Topics: Animals; Berberine; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell | 2019 |
Berberine Attenuates Vascular Remodeling and Inflammation in a Rat Model of Metabolic Syndrome.
Topics: Activating Transcription Factor 2; Animals; Aorta; Berberine; Disease Models, Animal; Inflammation; | 2015 |